Sun Pharma’s St. Peter Says Entry into Ophthalmology Going Strong

Jerry St. Peter, VP & head, ophthalmic business, says the ophthalmology newcomer is making great progress in building broad pipeline to treat eye disease including dry eye and ocular pain. In this interview he reviews several acquisitions and partnerships the company has made over the past 24 months.